GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Total Assets

Tauns Laboratories (TSE:197A) Total Assets : 円36,013 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Total Assets?

Tauns Laboratories's Total Assets for the quarter that ended in Dec. 2024 was 円36,013 Mil.

During the past 12 months, Tauns Laboratories's average Total Assets Growth Rate was 16.10% per year.

Total Assets is connected with ROA %. Tauns Laboratories's annualized ROA % for the quarter that ended in Dec. 2024 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Tauns Laboratories's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.


Tauns Laboratories Total Assets Historical Data

The historical data trend for Tauns Laboratories's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Total Assets Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
Total Assets
20,268.09 18,332.16 29,261.33

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24
Total Assets 20,268.09 18,332.16 30,447.14 29,261.33 36,012.54

Tauns Laboratories Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tauns Laboratories's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (A: Jun. 2024 )+Total Liabilities (A: Jun. 2024 )
=13666.758+15594.567
=29,261

Tauns Laboratories's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=16291.14+19721.398
=36,013

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tauns Laboratories  (TSE:197A) Total Assets Explanation

Total Assets is connected with ROA %.

Tauns Laboratories's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (29261.325+36012.538)/ 2 )
=0/32636.9315
=0.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tauns Laboratories's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (29261.325+36012.538)/ 2 )
=0/32636.9315
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tauns Laboratories Total Assets Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines